IPO Boutique

Vigil Neuroscience, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Vigil Neuroscience, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Vigil Neuroscience, Inc.VIGL -
NASDAQ
$15.00-$17.00 $14.00 $12.007 million1/7/2022
Morgan Stanley, Jefferies, Stifel, Guggenheim Securities
Co-Manager(s):
Health Care
Filing(s):

Filed 2021-11-19
Terms Added 2022-01-03



Vigil Neuroscience, Inc. Quote & Chart - Click for current quote - VIGL

About Vigil Neuroscience, Inc. (adapted from Vigil Neuroscience, Inc. prospectus):
They are a microglia-focused company dedicated to improving the lives of patients, caregivers and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "VIGL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved